Search Results - "Foj, L."

Development and internal validation of a novel PHI-nomogram to identify aggressive prostate cancer by Foj, L., Filella, X.

“…•PHI was significantly higher in men with aggressive prostate cancer.•PHI accuracy was higher than accuracy for PSA and %fPSA.•A PHI nomogram useful to predict…”
Get full text

Comparison of total, free and bioavailable 25-OH vitamin D determinations to evaluate its biological activity in healthy adults: the LabOscat study by Peris, P., Filella, X., Monegal, A., Guañabens, N., Foj, L., Bonet, M., Boquet, D., Casado, E., Cerdá, D., Erra, A., Gómez-Vaquero, C., Martínez, S., Montalá, N., Pittarch, C., Kanterewicz, E., Sala, M., Suris, X., Carrasco, J. L.

“…Summary Determination of different forms of 25-OHD (total, free and bioavailable) in healthy young women does not offer additional advantages over standard…”
Get full text

Variability of assay methods for total and free PSA after WHO standardization by Foj, L., Filella, X, Alcover, J., Augé, J. M., Escudero, J. M., Molina, R.

“…The variability of total PSA (tPSA) and free PSA (fPSA) results among commercial assays has been suggested to be decreased by calibration to World Health…”
Get full text

Emerging biomarkers in the diagnosis of prostate cancer by Filella, Xavier, Fernández-Galan, Esther, Fernández Bonifacio, Rosa, Foj, Laura

“…Prostate cancer (PCa) is the second most common cancer in men worldwide. A large proportion of PCa are latent, never destined to progress or affect the…”
Get full text